Old drug brings new hope for critically ill coronavirus patients

BMC-run hospitals have successfully tried an immunomodulatory drug to treat extremely critical Covid-19 cases. The drug, which costs Rs 60,000-a-doze, was administered to two patients in Nair Hospital and both showed remarkable recovery.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2WkqGPg
via IFTTT